Can circulating M30 and M65 levels be beneficial markers in the diagnosis and management of patients with complete hydatidiform mole?


İNCEBIYIK A., Vural M., CAMUZCUOĞLU H., TAŞKIN A., Camuzcuoglu A., HİLALİ N. G. , ...More

WIENER KLINISCHE WOCHENSCHRIFT, vol.128, 2016 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 128
  • Publication Date: 2016
  • Doi Number: 10.1007/s00508-015-0735-5
  • Title of Journal : WIENER KLINISCHE WOCHENSCHRIFT

Abstract

The objective of this study is to evaluate the prognostic value of M30 and M65 levels as markers of apoptotic activity and maternal serum oxidative stress in patients with complete hydatidiform mole (CHM).